Cargando…
Proto-oncogenic miR-744 is upregulated by transcription factor c-Jun via a promoter activation mechanism
Upregulation of miR-744 is associated with poor prognosis in many types of cancer patients, but it is still unclear how miR-744 becomes elevated in these tumors. In this study, we found that ectopic c-Jun elevated miR-744 expression, whereas c-Jun attenuation reduced miR-744 expression. Chromatin im...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5323131/ https://www.ncbi.nlm.nih.gov/pubmed/27533465 http://dx.doi.org/10.18632/oncotarget.11285 |
_version_ | 1782509972805910528 |
---|---|
author | Sha, Zhou Zhu, Xiaoxia Li, Na Li, Yiyi Li, Dianhe |
author_facet | Sha, Zhou Zhu, Xiaoxia Li, Na Li, Yiyi Li, Dianhe |
author_sort | Sha, Zhou |
collection | PubMed |
description | Upregulation of miR-744 is associated with poor prognosis in many types of cancer patients, but it is still unclear how miR-744 becomes elevated in these tumors. In this study, we found that ectopic c-Jun elevated miR-744 expression, whereas c-Jun attenuation reduced miR-744 expression. Chromatin immunoprecipitation assay confirmed the direct binding of c-Jun to the promoter of miR-744. The binding site of −343 to −349 bp within the most potential promoter like sequence of miR-744 was further validated by luciferase reporter gene assays. C-Jun-induced miR-744 upregulation could significantly promote migration and invasion of nasopharyngeal carcinoma cells and non-small cell lung cancer (NSCLC) cells, hence ectopic c-Jun was sufficient to rescue the migratory and invasive ability of these cells when miR-744 was knockdown. Additionally, a positive correlation between the expression levels of miR-744 and c-Jun was revealed in NSCLC samples with high (top 10%) level of miR-744 expression from the TCGA dataset. Taken together, our results demonstrated for the first time the regulatory mechanism of miR-744 transcription by c-Jun, providing a potential mechanism underlying the upregulation of miR-744 in cancers. |
format | Online Article Text |
id | pubmed-5323131 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | Impact Journals LLC |
record_format | MEDLINE/PubMed |
spelling | pubmed-53231312017-03-23 Proto-oncogenic miR-744 is upregulated by transcription factor c-Jun via a promoter activation mechanism Sha, Zhou Zhu, Xiaoxia Li, Na Li, Yiyi Li, Dianhe Oncotarget Research Paper Upregulation of miR-744 is associated with poor prognosis in many types of cancer patients, but it is still unclear how miR-744 becomes elevated in these tumors. In this study, we found that ectopic c-Jun elevated miR-744 expression, whereas c-Jun attenuation reduced miR-744 expression. Chromatin immunoprecipitation assay confirmed the direct binding of c-Jun to the promoter of miR-744. The binding site of −343 to −349 bp within the most potential promoter like sequence of miR-744 was further validated by luciferase reporter gene assays. C-Jun-induced miR-744 upregulation could significantly promote migration and invasion of nasopharyngeal carcinoma cells and non-small cell lung cancer (NSCLC) cells, hence ectopic c-Jun was sufficient to rescue the migratory and invasive ability of these cells when miR-744 was knockdown. Additionally, a positive correlation between the expression levels of miR-744 and c-Jun was revealed in NSCLC samples with high (top 10%) level of miR-744 expression from the TCGA dataset. Taken together, our results demonstrated for the first time the regulatory mechanism of miR-744 transcription by c-Jun, providing a potential mechanism underlying the upregulation of miR-744 in cancers. Impact Journals LLC 2016-08-13 /pmc/articles/PMC5323131/ /pubmed/27533465 http://dx.doi.org/10.18632/oncotarget.11285 Text en Copyright: © 2016 Sha et al. http://creativecommons.org/licenses/by/2.5/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Research Paper Sha, Zhou Zhu, Xiaoxia Li, Na Li, Yiyi Li, Dianhe Proto-oncogenic miR-744 is upregulated by transcription factor c-Jun via a promoter activation mechanism |
title | Proto-oncogenic miR-744 is upregulated by transcription factor c-Jun via a promoter activation mechanism |
title_full | Proto-oncogenic miR-744 is upregulated by transcription factor c-Jun via a promoter activation mechanism |
title_fullStr | Proto-oncogenic miR-744 is upregulated by transcription factor c-Jun via a promoter activation mechanism |
title_full_unstemmed | Proto-oncogenic miR-744 is upregulated by transcription factor c-Jun via a promoter activation mechanism |
title_short | Proto-oncogenic miR-744 is upregulated by transcription factor c-Jun via a promoter activation mechanism |
title_sort | proto-oncogenic mir-744 is upregulated by transcription factor c-jun via a promoter activation mechanism |
topic | Research Paper |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5323131/ https://www.ncbi.nlm.nih.gov/pubmed/27533465 http://dx.doi.org/10.18632/oncotarget.11285 |
work_keys_str_mv | AT shazhou protooncogenicmir744isupregulatedbytranscriptionfactorcjunviaapromoteractivationmechanism AT zhuxiaoxia protooncogenicmir744isupregulatedbytranscriptionfactorcjunviaapromoteractivationmechanism AT lina protooncogenicmir744isupregulatedbytranscriptionfactorcjunviaapromoteractivationmechanism AT liyiyi protooncogenicmir744isupregulatedbytranscriptionfactorcjunviaapromoteractivationmechanism AT lidianhe protooncogenicmir744isupregulatedbytranscriptionfactorcjunviaapromoteractivationmechanism |